Literature DB >> 9401371

Inspiratory muscle dysfunction as a cause of death in COPD patients.

P Sliwinski1, P T Macklem.   

Abstract

Although fatigue of the inspiratory muscles has been well documented, its prevalence in patients with chronic obstructive pulmonary disease (COPD) and its influence on mortality are unknown, because of the lack of a simple, clinically available diagnostic test. The hypothesis and experimental evidence relating inspiratory muscle dysfunction to the development of hypercapnia and hypercapnic ventilatory failure are reviewed. Since a poor prognosis in COPD is associated with carbon dioxide retention, inspiratory muscle weakness and/or fatigue may have an association with survival in these patients.

Entities:  

Mesh:

Year:  1997        PMID: 9401371

Source DB:  PubMed          Journal:  Monaldi Arch Chest Dis        ISSN: 1122-0643


  4 in total

1.  Obesity modulates diaphragm curvature in subjects with and without COPD.

Authors:  Aladin M Boriek; Michael A Lopez; Cristina Velasco; Azam A Bakir; Anna Frolov; Shari Wynd; Tony G Babb; Nicola A Hanania; Eric A Hoffman; Amir Sharafkhaneh
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2017-09-13       Impact factor: 3.619

2.  Respiratory muscle strength and the risk of incident cardiovascular events.

Authors:  J van der Palen; T D Rea; T A Manolio; T Lumley; A B Newman; R P Tracy; P L Enright; B M Psaty
Journal:  Thorax       Date:  2004-12       Impact factor: 9.139

3.  Respiratory muscle injury, fatigue and serum skeletal troponin I in rat.

Authors:  Jeremy A Simpson; Jennifer Van Eyk; Steve Iscoe
Journal:  J Physiol       Date:  2003-12-12       Impact factor: 5.182

4.  Treatment with a corticotrophin releasing factor 2 receptor agonist modulates skeletal muscle mass and force production in aged and chronically ill animals.

Authors:  Richard T Hinkle; Frank R Lefever; Elizabeth T Dolan; Deborah L Reichart; Janice M Zwolshen; Timothy P Oneill; Kris G Maloney; John P Mattson; Leonardo F Ferreira; Timothy I Musch; David C Poole; Robert J Isfort
Journal:  BMC Musculoskelet Disord       Date:  2011-01-14       Impact factor: 2.362

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.